Skip to main content

Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs

Summary

The coagulation disturbance observed during severe acute pancreatitis before and after the infusion of a new synthetic low molecular weight protease inhibitor (Fut-175) was compared. The coagulofibrinolytic changes after acute pancreatitis was induced by the intraductal injection of an autologous bile and trypsin mixture showed decreased platelet counts, decreased plasma fibrinogen levels, prolonged partial prothrombin time and increased fibrinogen degradation products. In addition, markers of hypercoagulation showed increased fibrin-opeptide A and decreased antithrombin III. The two markers of fibrinolysis showed increased Bβ15–42 immunoreactive peptide and decreased α2 antiplasmin. After the infusisn of Fut-175, the coagulo-fibrinolytic abnormalities, which were bserved during severe acute pancreatitis without infusion of Fut-175, were improved. Furthermore, Fut-175 could suppress the rise in fibrino-peptide A and Bβ15–42 immunoreactive peptide and decrease in antithrombin III and α2 antiplasmin. Thus, Fut-175 seems to be an effective inhitor of protease-mediated hypercoagulation and fibrinolysis in severe acute pancreatitis.

This is a preview of subscription content, access via your institution.

References

  1. Shinowara GY, Stutman LH, Waltin IJ, et al: Hyper-coagulability in acute pancreatitis. Am J Surg 1963;105:714–719

    PubMed  Article  CAS  Google Scholar 

  2. Ransson JH, Lachner H, Berman IR, et al: The relationship of coagulation factors to clinical complications of acute pancreatitis. Surgery 1977;81:502–511

    Google Scholar 

  3. Mckay DG: Proteolytic enzymes in disseminated intravascular coagulation. Harper & Row, New York. 1965

    Google Scholar 

  4. Satake K, Uchima K, Umeyama K, et al: Effects upon blood coagulation in dogs of experimentally induced pancreatitis and the infusion of pancreatic juice. Surg Gynecol Obstet 1981; 153: 341–345

    PubMed  CAS  Google Scholar 

  5. Kwaan HC, Anderson MC, Gramatica L: A study of pancreatic enzymes as a factor in the pathogenesis of disseminated intravascular coagulation during acute pancreatitis. Surgery 1971;69: 633–676

    Google Scholar 

  6. Satake K: Acute necrotic pancreatitis and disseminated intravascular coagulation. J Jap Surg Soc 1983:84:891–894

    CAS  Google Scholar 

  7. Lasson A, Ohlsson K: Comsunptive coagulopathy, fibrinolysis and protease-antiprotease interaction during acute human pancreatitis. Thromb Res 1986;41:167–183

    PubMed  Article  CAS  Google Scholar 

  8. Markwardt F: Pharmacological control of blood coagulation by synthetic, low-molecular-weight inhibitors of clotting enzymes. A new concept of anticoagulants. Trends in pharmacologie sciences Feb. 1980

  9. Iwaki M, Ino Y, Motoyoshi A, et al: Pharmacological Studies of Fut-175, Nafamostat Mesilate. V. Effects on the pancreatic enzymes and experimental acute pancreatitis in rats. Jap J Pharm 1986:41:155–162

    PubMed  CAS  Google Scholar 

  10. Quick AJ, Stanly BM, Bancrofs FW: A study of the coagulation defect in hemophilia and in juandice. Am J Med Sei 1935;190: 601–603

    Google Scholar 

  11. Langdell RD, Wagner RH, Brinkhous KM: Effect of antihemophilic factor on one stage clotting time. Surgery 1971;69: 663–665

    Google Scholar 

  12. Dati F, Bartheis M, Conard J, et al: Multicentric evaluation of a chromogenic substrate method for photometric dermination of prothrombin time. Thromb Haemostas 1987:3:856–865

    Google Scholar 

  13. Izquierdo R, Sandberg L, Squillaci G, et al: Effects of protease inhibitors on coagulation abnormalities in acute canine pancreatitis. Am Surg 1984:50:317–323

    PubMed  CAS  Google Scholar 

  14. Agarwal MB, Kambar MS, Bapat PD, et al: Consumptive coagulopathy and fibrinolysis in experimental acute pancreatitis. J Postgrad Med 1982:28:214–217

    PubMed  CAS  Google Scholar 

  15. Murhy D, Imrie CW, Daoidron JF: Haematologic abnormalities in acute pancreatitis. A prospective study. J Postgrad Med 1977;53:310–314

    Article  Google Scholar 

  16. Aaasen AD, Kierulf P, Ruud TE, et al: Studies on pathological plasma proteolysis in patients with acute pancreatitis. A preliminary report. Acta Chir Scand 1982;509 Suppl:83–87

    Google Scholar 

  17. Carey LC: Extra-abdominal manifestation of acute pancreatitis. Surgery 1979:86:337–342

    PubMed  CAS  Google Scholar 

  18. Warshaw AL, Lesser R, Rie M, et al: The pathogenesis of pulmonary edema in acute pancreatitis. Ann Surg 1975;182:505–509

    PubMed  CAS  Article  Google Scholar 

  19. Ojiro M: Hemostatic abnormalities as the cause of MOF and DIC in acute pancreatitis. Prog Abd Emerg Med 1986;6;199–202

    Google Scholar 

  20. Satake K, Rozmanith JS, Appert H, et al: Hyppotension and release of kinin-forming enzyme into ascitic fluid exudate during experimental pancreatitis in dogs. Ann Surg 1973;177:497–502

    PubMed  Article  CAS  Google Scholar 

  21. Satake K, Rozmanith JS, Appert H, et al: Hemodynamic change and bradykinin levels in plasma and lymph during experimental acute pancreatitis in dogs. Ann Surg 1973;178:659–662

    PubMed  Article  CAS  Google Scholar 

  22. Thal AP, Kobold EE, Hollenberg MJ, et al: The release of vasoactive substances in acute pancreatitis. Am J Surg 1963;105:708–713

    PubMed  Article  CAS  Google Scholar 

  23. Popieraitis AS, Thompson AC: The site of bradykinin release in acute experimental pancreatitis. Arch Surg 1969;98:73–76

    PubMed  CAS  Google Scholar 

Download references

Author information

Affiliations

Authors

Additional information

This work is supported by a part of grant-in aid of pancreatic disease of Japanese Ministry of Health and Welfare.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Satake, K., Ha, Ss., Hiura, A. et al. Effect of a synthetic protease inhibitor (Fut-175) on coagulation abnormalities during experimental acute pancreatitis in dogs. Gastroenterol Jpn 25, 720–726 (1990). https://doi.org/10.1007/BF02779186

Download citation

  • Received:

  • Accepted:

  • Issue Date:

  • DOI: https://doi.org/10.1007/BF02779186

Key words

  • coagulation abnormalities
  • severe acute pancreatitis
  • synthetic low molecular weight protease inhibitor (Fut-175)